Variant report
| Variant | nsv523031 |
|---|---|
| Chromosome Location | chr7:103457789-103470499 |
| allele | n/a |
| Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:14)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
| No data |
| No data |
(count:14 , 50 per page) page:
1
| No. | Distal block | Cell Line | Cell type | Cell Stage |
|---|---|---|---|---|
| 1 | chr10:45348502..45349200-chr7:103463744..103464468,2 | MCF-7 | breast: | |
| 2 | chr7:103455999..103458668-chr7:103467643..103469823,2 | K562 | blood: | |
| 3 | chr7:103459433..103461236-chr7:103461916..103464408,2 | K562 | blood: | |
| 4 | chr7:103455999..103458668-chr7:103467643..103469823,2 | K562 | blood: | |
| 5 | chr7:103462200..103464202-chr7:103470870..103473590,2 | K562 | blood: | |
| 6 | chr7:103459433..103461236-chr7:103461916..103464408,2 | K562 | blood: | |
| 7 | chr20:55884808..55887804-chr7:103468057..103471037,2 | MCF-7 | breast: | |
| 8 | chr7:103458610..103460709-chr7:103463601..103466082,3 | K562 | blood: | |
| 9 | chr7:103466010..103468744-chr7:103470404..103473260,3 | K562 | blood: | |
| 10 | chr7:103458610..103460709-chr7:103463601..103466082,3 | K562 | blood: | |
| 11 | chr7:103467206..103468826-chr7:103482510..103485701,3 | K562 | blood: | |
| 12 | chr7:103453840..103455348-chr7:103457770..103460574,2 | K562 | blood: | |
| 13 | chr7:103452464..103456150-chr7:103461161..103465020,4 | K562 | blood: | |
| 14 | chr7:103466010..103468744-chr7:103470404..103473260,3 | K562 | blood: |
| No data |
| No data |
| No data |
| Variant related genes | Relation type |
|---|---|
| ENSG00000252064 | chromatin interactions |
| No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
|---|---|---|---|---|---|---|---|
| 1 | rs13225455 | chr7:103457789-103457790 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | mRNA abundance |
| 2 | rs262365 | chr7:103457817-103457818 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 3 | rs532925018 | chr7:103457855-103457856 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 4 | rs576595890 | chr7:103457935-103457936 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 5 | rs190709506 | chr7:103457948-103457949 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 6 | rs183277250 | chr7:103457986-103457987 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 7 | rs551350267 | chr7:103458110-103458111 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 8 | rs563070005 | chr7:103458120-103458121 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 9 | rs377482983 | chr7:103458133-103458134 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 10 | rs187921374 | chr7:103458164-103458165 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 11 | rs192899627 | chr7:103458213-103458214 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 12 | rs529712727 | chr7:103458226-103458227 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 13 | rs185392795 | chr7:103458238-103458239 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 14 | rs569444376 | chr7:103458247-103458248 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 15 | rs147455099 | chr7:103458248-103458249 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 16 | rs262364 | chr7:103458263-103458264 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 17 | rs262363 | chr7:103458303-103458304 | Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 18 | rs145612499 | chr7:103458362-103458363 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 19 | rs370302859 | chr7:103458385-103458386 | Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 20 | rs533493772 | chr7:103458404-103458405 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 21 | rs71154371 | chr7:103458408-103458409 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 22 | rs71558650 | chr7:103458410-103458411 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 23 | rs372884860 | chr7:103458425-103458426 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 24 | rs187915120 | chr7:103458428-103458429 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 25 | rs536685360 | chr7:103458457-103458458 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 26 | rs7808351 | chr7:103458478-103458479 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 27 | rs576659893 | chr7:103458485-103458486 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 28 | rs262362 | chr7:103458509-103458510 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 29 | rs192942805 | chr7:103458525-103458526 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 30 | rs262361 | chr7:103458537-103458538 | Enhancers Weak transcription | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
| 31 | rs540839568 | chr7:103458589-103458590 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 32 | rs577038254 | chr7:103458632-103458633 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 33 | rs78097787 | chr7:103458668-103458669 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 34 | rs80352042 | chr7:103458674-103458675 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 35 | rs74845564 | chr7:103458706-103458707 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 36 | rs76420058 | chr7:103458707-103458708 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 37 | rs147305115 | chr7:103458708-103458709 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 38 | rs183683291 | chr7:103458747-103458748 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 39 | rs79789841 | chr7:103458768-103458769 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 40 | rs532757365 | chr7:103458788-103458789 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 41 | rs542806906 | chr7:103458869-103458870 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 42 | rs370043910 | chr7:103458873-103458874 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 43 | rs547661404 | chr7:103458904-103458905 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 44 | rs566391849 | chr7:103458912-103458913 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 45 | rs536544310 | chr7:103458996-103458997 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 46 | rs548646315 | chr7:103458997-103458998 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 47 | rs570076290 | chr7:103459031-103459032 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 48 | rs113783237 | chr7:103459034-103459035 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 49 | rs118039418 | chr7:103459043-103459044 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| 50 | rs142396553 | chr7:103459058-103459059 | Enhancers Weak transcription | n/a | n/a | Overlapped CNVs | n/a |
| Disease | PMID | Source |
|---|---|---|
| Basal cell lymphoma | 17170743 | CNVD |
| Esophageal squamous carcinoma | 21637470 | CNVD |
| Ewing''s sarcoma | 21437220 | CNVD |
| Glioblastoma multiforme | 21080181 | CNVD |
| Thyroid cancer | 19087340 | CNVD |
| Seminomas | 18059402 | CNVD |
| Testicular cancer | 18059402 | CNVD |
| Chronic lymphocytic leukemia | 21546498 | CNVD |
| Autism | 19415332 | CNVD |
| Medulloblastoma | 21979893 | CNVD |
| Pleomorphic xanthoastrocytoma | 20730472 | CNVD |
| T-cell lymphomas | 19863542 | CNVD |
| Malaria | 21533027 | CNVD |
| Melanoma | 18172304 | CNVD |
| Renal cell carcinoma | 19461508 | CNVD |
| head and neck squamous cell carcinoma | 19289630 | CNVD |
| Acute lymphoblastic leukemia | 20435627 | CNVD |
| Ewing''s sarcoma | 17952124 | CNVD |
| Autism | 22495311 | CNVD |
| Wilms tumour | 21544195 | CNVD |
| Non-small cell lung cancer | 21829676 | CNVD |
| Gastric cancer | 24379144 | CNVD |
| Glioblastoma multiforme | 17002787 | CNVD |
| T-cell prolymphocytic leukemia | 19278963 | CNVD |
| Lissencephaly | 21572526 | CNVD |
| Breast cancer | 17603634 | CNVD |
| Liposarcoma | 21253554 | CNVD |
| Breast cancer | 16397240 | CNVD |
| Acute myeloid leukemia | 16864856 | CNVD |
| Squamous cell cancer | 21044232 | CNVD |
| Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
| Astrocytoma | 17387387 | CNVD |
| Glioblastoma multiforme | 17387387 | CNVD |
| Low-grade fibromyxoid sarcoma | 0 | CNVD |
| Oligodendroglial tumors | 17285580 | CNVD |
| Endometrial cancer | 22040021 | CNVD |
| Burkitt''s lymphoma | 18698080 | CNVD |
| Breast cancer | 21264507 | CNVD |
| Shwachman-Diamond syndrome | 22934832 | CNVD |
| Colorectal cancer | 19359472 | CNVD |
| Cutaneous malignant melanoma | 17690212 | CNVD |
| Leukemia | 17361228 | CNVD |
| Breast cancer | 16461572 | CNVD |
| Peripheral t-cell lymphoma | 19118030 | CNVD |
| Malignant melanoma | 17690212 | CNVD |
| Renal cell carcinoma | 18592004 | CNVD |
| Acute promyelocytic leukemia | 19109227 | CNVD |
| Multiple myeloma | 17550852 | CNVD |
| small cell lung cancer | 20016488 | CNVD |
| Hodgkin''s lymphoma | 17606441 | CNVD |
| Neurodevelopmental disorder | 22521361 | CNVD |
| abortions and stillbirths | 19751515 | CNVD |
| Acute lymphoblastic leukemia | 21980252 | CNVD |
| Acute myeloid leukemia | 20729466 | CNVD |
| Lung cancer | 18438408 | CNVD |
| Metanephric adenoma | 20802469 | CNVD |
| Prostate cancer | 16461572 | CNVD |
| Endometrioid adenocarcinoma | 16974079 | CNVD |
| Non-syndromic sensorineural hearing loss | 21987784 | CNVD |
| Burkitt''s lymphoma | 19759907 | CNVD |
| Malignant melanoma | 17260012 | CNVD |
| Myelodysplastic syndrome | 21251322 | CNVD |
| Acute myeloid leukemia | 21251322 | CNVD |
| Breast cancer | 21785460 | CNVD |
| Chronic myeloid leukemia | 21384125 | CNVD |
| Bladder cancer | 21909424 | CNVD |
| Biliary cancer | 19435499 | CNVD |
| Myelofibrosis | 22110671 | CNVD |
| Splenic marginal zone lymphoma | 21957467 | CNVD |
| Breast cancer | 16608533 | CNVD |
| Primary central nervous system lymphoma | 21088137 | CNVD |
| Liver carcinoma | 19366792 | CNVD |
| T-cell acute lymphoblastic leukemia | 19406988 | CNVD |
| Adenocarcinoma | 19607727 | CNVD |
| Multiple myeloma | 16461302 | CNVD |
| Breast cancer | 21858162 | CNVD |
| Emphysema | 19352772 | CNVD |
| Effusion lymphoma | 18079361 | CNVD |
| Medulloblastoma | 17653508 | CNVD |
| Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
| Autism | 19401682 | CNVD |
| Neuroticism | 17667963 | CNVD |
| Prostate cancer | 18632612 | CNVD |
| Acute lymphoblastic leukemia | 22237106 | CNVD |
| Cancer | 19907438 | CNVD |
| Breast cancer | 21364760 | CNVD |
| abnormal development | 18461090 | CNVD |
| lymphocytic leukemia | 21291569 | CNVD |
| Prostate cancer | 21147910 | CNVD |
| No. | Chromosome Location | Chromatin state | Cell line | Tissue |
|---|---|---|---|---|
| 1 | chr7:103455200-103457800 | Enhancers | HepG2 | liver |
| 2 | chr7:103457800-103472000 | Weak transcription | HepG2 | liver |
| 3 | chr7:103458400-103459400 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
| 4 | chr7:103461200-103482400 | Weak transcription | H1 BMP4 Derived Mesendoderm Cultured Cells | ES cell derived |
| 5 | chr7:103464800-103465800 | Weak transcription | K562 | blood |
| 6 | chr7:103465800-103466600 | Strong transcription | K562 | blood |
| 7 | chr7:103466600-103481800 | Weak transcription | K562 | blood |
| 8 | chr7:103469600-103470000 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
| 9 | chr7:103470000-103470200 | Weak transcription | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |
| 10 | chr7:103470200-103470600 | Enhancers | Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells | embryonic stem cell |






